ArticleOncoTargets and therapy2017

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report.

Fu-Chao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.